Resona Asset Management Co. Ltd. Invests $1.51 Million in HealthEquity, Inc. (NASDAQ:HQY)

Resona Asset Management Co. Ltd. acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 15,689 shares of the company's stock, valued at approximately $1,505,000.

Several other hedge funds have also recently bought and sold shares of HQY. Arcadia Investment Management Corp MI purchased a new stake in HealthEquity during the fourth quarter worth about $26,000. Smartleaf Asset Management LLC grew its holdings in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares in the last quarter. Proficio Capital Partners LLC purchased a new stake in HealthEquity during the 4th quarter worth approximately $39,000. UMB Bank n.a. lifted its holdings in HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after buying an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ boosted its position in HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after buying an additional 445 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of recent research reports. Wells Fargo & Company upped their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. KeyCorp cut their target price on shares of HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Monday, March 24th. The Goldman Sachs Group decreased their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price objective for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a research report on Friday. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $112.58.

Remove Ads

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. This trade represents a 13.55 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the transaction, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. This represents a 6.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 20,381 shares of company stock worth $1,781,432. Corporate insiders own 2.20% of the company's stock.

HealthEquity Stock Performance

HQY traded up $0.17 on Tuesday, reaching $83.53. The company had a trading volume of 149,921 shares, compared to its average volume of 758,971. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The stock has a market capitalization of $7.23 billion, a PE ratio of 76.53, a P/E/G ratio of 1.60 and a beta of 0.49. The stock has a 50-day moving average price of $97.05 and a 200-day moving average price of $96.45.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.